AGM-1470 -: TNP-470 -: Oncolytic -: Angiogenesis inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1174 / 1177
页数：4
相关论文
共 50 条
  • [21] 血管生成抑制剂TNP-470(AGM-1470)的研究和应用进展
    钱朝南
    中国肿瘤生物治疗杂志, 1998, (02) : 151 - 156
  • [22] ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) POTENTLY INHIBITS THE TUMOR-GROWTH OF HORMONE-INDEPENDENT HUMAN BREAST AND PROSTATE CARCINOMA CELL-LINES
    YAMAOKA, M
    YAMAMOTO, T
    IKEYAMA, S
    SUDO, K
    FUJITA, T
    CANCER RESEARCH, 1993, 53 (21) : 5233 - 5236
  • [23] Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder
    Inoue, K
    Chikazawa, M
    Fukata, S
    Yoshikawa, C
    Shuin, T
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2389 - 2398
  • [24] TREATMENT OF MURINE HEMANGIOENDOTHELIOMAS WITH THE ANGIOGENESIS INHIBITOR AGM-1470
    OREILLY, MS
    BREM, H
    FOLKMAN, J
    JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (02) : 325 - 330
  • [25] THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR
    FIGG, WD
    PLUDA, JM
    WYVILL, K
    SAVILLE, W
    THIBAULT, A
    MCCALL, NA
    SOGOCIO, T
    REED, E
    BRODER, S
    YARCHOAN, R
    CLINICAL RESEARCH, 1994, 42 (02): : A253 - A253
  • [26] The pharmacokinetics of TNP-470, a new angiogenesis inhibitor
    Figg, WD
    Pluda, JM
    Lush, RM
    Saville, MW
    Wyvill, K
    Reed, E
    Yarchoan, R
    PHARMACOTHERAPY, 1997, 17 (01): : 91 - 97
  • [27] Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
    de Bandt, M
    Grossin, M
    Weber, AJ
    Chopin, M
    Elbim, C
    Pla, M
    Gougerot-Pocidalo, MA
    Gaudry, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : 2056 - 2063
  • [28] TNP-470: an angiogenesis inhibitor in clinical development for cancer
    Kruger, EA
    Figg, WD
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (06) : 1383 - 1396
  • [29] In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11
    Maier, JAM
    Delia, D
    Thorpe, PE
    Gasparini, G
    ANTI-CANCER DRUGS, 1997, 8 (03) : 238 - 244
  • [30] TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy
    Denton, MD
    Magee, C
    Melter, M
    Dharnidharka, VR
    Sayegh, MH
    Briscoe, DM
    TRANSPLANTATION, 2004, 78 (08) : 1218 - 1221
12345